Based on the Dentsply Sirona Inc stock forecast from 11 analysts, the average analyst target price for Dentsply Sirona Inc is USD 23.65 over the next 12 months. Dentsply Sirona Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Dentsply Sirona Inc is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Dentsply Sirona Inc’s stock price was USD 13.58. Dentsply Sirona Inc’s stock price has changed by -9.04% over the past week, -16.48% over the past month and -57.97% over the last year.
No recent analyst target price found for Dentsply Sirona Inc
No recent average analyst rating found for Dentsply Sirona Inc
Company Overview Dentsply Sirona Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. Its Essential Dental Solutions segment offers motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. Its Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina. Read Less
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental ...Read More
Frequently Asked Questions About Dentsply Sirona Inc (XRAY) Stock
Based on ratings from 11 analysts Dentsply Sirona Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 10 buy, sell and 10 hold ratings.
XRAY stock's dividend yield is 4.71%.
Our analysis grades XRAY stock's dividend yield at A+. This means that XRAY stock's dividend yield is above 100% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this XRAY may be a good dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for XRAY is USD 23.65 over the next 12 months. The maximum analyst target price is USD 36 while the minimum anlayst target price is USD 18.
XRAY stock's Price/Earning ratio is 22.28.
Our analysis grades XRAY stock's Price / Earning ratio at D-. This means that XRAY stock's Price/Earning ratio is above 38% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this XRAY may be fairly valued for its sector
The last closing price of XRAY's stock was USD 13.58.
The most recent market capitalization for XRAY is USD 2.70B.
Based on targets from 11 analysts, the average taret price for XRAY is projected at USD 23.65 over the next 12 months.
This means that XRAY's stock price may go up by +74.15% over the next 12 months.
We can't find any ETFs which contains Dentsply Sirona Inc's stock.
As per our most recent records Dentsply Sirona Inc has 14,000 Employees.
Dentsply Sirona Inc's registered address is 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607.
You can get more information about it from Dentsply Sirona Inc's website at https://www.dentsplysirona.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Dentsply Sirona Inc (XRAY) Stock
Based on ratings from 11 analysts Dentsply Sirona Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 10 buy, sell and 10 hold ratings.
XRAY stock's dividend yield is 4.71%.
Our analysis grades XRAY stock's dividend yield at A+. This means that XRAY stock's dividend yield is above 100% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this XRAY may be a good dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for XRAY is USD 23.65 over the next 12 months. The maximum analyst target price is USD 36 while the minimum anlayst target price is USD 18.
XRAY stock's Price/Earning ratio is 22.28.
Our analysis grades XRAY stock's Price / Earning ratio at D-. This means that XRAY stock's Price/Earning ratio is above 38% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this XRAY may be fairly valued for its sector
The last closing price of XRAY's stock was USD 13.58.
The most recent market capitalization for XRAY is USD 2.70B.
Based on targets from 11 analysts, the average taret price for XRAY is projected at USD 23.65 over the next 12 months.
This means that XRAY's stock price may go up by +74.15% over the next 12 months.
We can't find any ETFs which contains Dentsply Sirona Inc's stock.
As per our most recent records Dentsply Sirona Inc has 14,000 Employees.
Dentsply Sirona Inc's registered address is 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607.
You can get more information about it from Dentsply Sirona Inc's website at https://www.dentsplysirona.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XRAY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
